These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 28933546)

  • 1. Rational Design of Selective Adenine-Based Scaffolds for Inactivation of Bacterial Histidine Kinases.
    Goswami M; Wilke KE; Carlson EE
    J Med Chem; 2017 Oct; 60(19):8170-8182. PubMed ID: 28933546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repurposing Hsp90 inhibitors as antibiotics targeting histidine kinases.
    Vo CD; Shebert HL; Zikovich S; Dryer RA; Huang TP; Moran LJ; Cho J; Wassarman DR; Falahee BE; Young PD; Gu GH; Heinl JF; Hammond JW; Jackvony TN; Frederick TE; Blair JA
    Bioorg Med Chem Lett; 2017 Dec; 27(23):5235-5244. PubMed ID: 29110989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Rational Design, Synthesis, and Antimicrobial Properties of Thiophene Derivatives That Inhibit Bacterial Histidine Kinases.
    Boibessot T; Zschiedrich CP; Lebeau A; Bénimèlis D; Dunyach-Rémy C; Lavigne JP; Szurmant H; Benfodda Z; Meffre P
    J Med Chem; 2016 Oct; 59(19):8830-8847. PubMed ID: 27575438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inactivation of multiple bacterial histidine kinases by targeting the ATP-binding domain.
    Wilke KE; Francis S; Carlson EE
    ACS Chem Biol; 2015 Jan; 10(1):328-35. PubMed ID: 25531939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening serine/threonine and tyrosine kinase inhibitors for histidine kinase inhibition.
    Wilke KE; Fihn CA; Carlson EE
    Bioorg Med Chem; 2018 Oct; 26(19):5322-5326. PubMed ID: 29706527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bacterial histidine kinases as novel antibacterial drug targets.
    Bem AE; Velikova N; Pellicer MT; Baarlen Pv; Marina A; Wells JM
    ACS Chem Biol; 2015 Jan; 10(1):213-24. PubMed ID: 25436989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crystal structure of a polyhistidine-tagged recombinant catalytic subunit of cAMP-dependent protein kinase complexed with the peptide inhibitor PKI(5-24) and adenosine.
    Narayana N; Cox S; Shaltiel S; Taylor SS; Xuong N
    Biochemistry; 1997 Apr; 36(15):4438-48. PubMed ID: 9109651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural basis of Src tyrosine kinase inhibition with a new class of potent and selective trisubstituted purine-based compounds.
    Dalgarno D; Stehle T; Narula S; Schelling P; van Schravendijk MR; Adams S; Andrade L; Keats J; Ram M; Jin L; Grossman T; MacNeil I; Metcalf C; Shakespeare W; Wang Y; Keenan T; Sundaramoorthi R; Bohacek R; Weigele M; Sawyer T
    Chem Biol Drug Des; 2006 Jan; 67(1):46-57. PubMed ID: 16492148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-activity relationship in a purine-scaffold compound series with selectivity for the endoplasmic reticulum Hsp90 paralog Grp94.
    Patel HJ; Patel PD; Ochiana SO; Yan P; Sun W; Patel MR; Shah SK; Tramentozzi E; Brooks J; Bolaender A; Shrestha L; Stephani R; Finotti P; Leifer C; Li Z; Gewirth DT; Taldone T; Chiosis G
    J Med Chem; 2015 May; 58(9):3922-43. PubMed ID: 25901531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activity-based ATP analog probes for bacterial histidine kinases.
    Lembke HK; Carlson EE
    Methods Enzymol; 2022; 664():59-84. PubMed ID: 35331379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angucycline antibiotic waldiomycin recognizes common structural motif conserved in bacterial histidine kinases.
    Eguchi Y; Okajima T; Tochio N; Inukai Y; Shimizu R; Ueda S; Shinya S; Kigawa T; Fukamizo T; Igarashi M; Utsumi R
    J Antibiot (Tokyo); 2017 Mar; 70(3):251-258. PubMed ID: 27999439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ATP-binding site of bacterial enzymes as a target for antibacterial drug design.
    Škedelj V; Tomašić T; Mašič LP; Zega A
    J Med Chem; 2011 Feb; 54(4):915-29. PubMed ID: 21235241
    [No Abstract]   [Full Text] [Related]  

  • 13. A high-throughput TNP-ATP displacement assay for screening inhibitors of ATP-binding in bacterial histidine kinases.
    Guarnieri MT; Blagg BS; Zhao R
    Assay Drug Dev Technol; 2011 Apr; 9(2):174-83. PubMed ID: 21050069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting the hydrophobic region of Hsp90's ATP binding pocket with novel 1,3,5-triazines.
    Lee T; Seo YH
    Bioorg Med Chem Lett; 2013 Dec; 23(23):6427-31. PubMed ID: 24125885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of 8-arylsulfanyl, 8-arylsulfoxyl, and 8-arylsulfonyl adenine derivatives as inhibitors of the heat shock protein 90.
    Llauger L; He H; Kim J; Aguirre J; Rosen N; Peters U; Davies P; Chiosis G
    J Med Chem; 2005 Apr; 48(8):2892-905. PubMed ID: 15828828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bacterial Histidine Kinases: Overexpression, Purification, and Inhibitor Screen.
    Gajdiss M; Türck M; Bierbaum G
    Methods Mol Biol; 2017; 1520():247-259. PubMed ID: 27873257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis and biological evaluation of novel aryldiketo acids with enhanced antibacterial activity against multidrug resistant bacterial strains.
    Cvijetić IN; Verbić TŽ; Ernesto de Resende P; Stapleton P; Gibbons S; Juranić IO; Drakulić BJ; Zloh M
    Eur J Med Chem; 2018 Jan; 143():1474-1488. PubMed ID: 29133041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamics of conserved waters in human Hsp90: implications for drug design.
    Yan A; Grant GH; Richards WG
    J R Soc Interface; 2008 Dec; 5 Suppl 3(Suppl 3):S199-205. PubMed ID: 18826913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-activity relationships in purine-based inhibitor binding to HSP90 isoforms.
    Wright L; Barril X; Dymock B; Sheridan L; Surgenor A; Beswick M; Drysdale M; Collier A; Massey A; Davies N; Fink A; Fromont C; Aherne W; Boxall K; Sharp S; Workman P; Hubbard RE
    Chem Biol; 2004 Jun; 11(6):775-85. PubMed ID: 15217611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of new Hsp90 inhibitors based on 3,4-isoxazolediamide scaffold using QSAR study, molecular docking and molecular dynamic simulation.
    Abbasi M; Sadeghi-Aliabadi H; Amanlou M
    Daru; 2017 Jun; 25(1):17. PubMed ID: 28666484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.